Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 393 entries
Sorted by: Best Match Show Resources per page
Gender (in) equity in the academy: Subtle mechanisms and the production of inequality

Geoscience Opportunities for Leadership in Diversity AND Program Evaluation

Gatta ML.
GSID: COjp_m1sx5oJ
PA Roos, ML Gatta - Research in Social Stratification and Mobility, 2009 - Elsevier

Researchers have shifted in recent years from explanations that posit overt discrimination as the causal mechanism producing gender inequity, to more subtle forms of favoritism and/or barriers to advancement. Working in the latter tradition, we focus on how subtle...

Cite
Roos, P. A., & Gatta, M. L. (2009). Gender (in) equity in the academy: Subtle mechanisms and the production of inequality. Research in Social Stratification and Mobility, 27(3), 177-200.
Roos, Patricia A., and Mary L. Gatta. "Gender (in) equity in the academy: Subtle mechanisms and the production of inequality." Research in Social Stratification and Mobility 27.3 (2009): 177-200.
Copy Download .nbib Format: MLA
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice.

Clinical and molecular allergy : CMA

Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M.
PMID: 27499704
Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016.

BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natural...

Cite
Petrarca C, Clemente E, Amato V, et al. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016;14:7doi: 10.1186/s12948-016-0044-1.
Petrarca, C., Clemente, E., Amato, V., Gatta, A., Cortese, S., Lamolinara, A., Rossi, C., Zanotta, S., Mistrello, G., Paganelli, R., & Di Gioacchino, M. (2016). Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clinical and molecular allergy : CMA, 147. https://doi.org/10.1186/s12948-016-0044-1
Petrarca, Claudia, et al. "Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice." Clinical and molecular allergy : CMA vol. 14 (2016): 7. doi: https://doi.org/10.1186/s12948-016-0044-1
Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016. PMID: 27499704; PMCID: PMC4975903.
Copy Download .nbib Format: NLM
Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P.

Nature chemical biology

Lassak J, Keilhauer EC, Fürst M, Wuichet K, Gödeke J, Starosta AL, Chen JM, Søgaard-Andersen L, Rohr J, Wilson DN, Häussler S, Mann M, Jung K.
PMID: 25785429
Nat Chem Biol. 2015 Apr;11(4):299. doi: 10.1038/nchembio0415-299d.

No abstract available.

Cite
Lassak J, Keilhauer EC, Fürst M, et al. Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P. Nat Chem Biol. 2015;11(4):299doi: 10.1038/nchembio0415-299d.
Lassak, J., Keilhauer, E. C., Fürst, M., Wuichet, K., Gödeke, J., Starosta, A. L., Chen, J. M., Søgaard-Andersen, L., Rohr, J., Wilson, D. N., Häussler, S., Mann, M., & Jung, K. (2015). Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P. Nature chemical biology, 11(4), 299. https://doi.org/10.1038/nchembio0415-299d
Lassak, Jürgen, et al. "Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P." Nature chemical biology vol. 11,4 (2015): 299. doi: https://doi.org/10.1038/nchembio0415-299d
Lassak J, Keilhauer EC, Fürst M, Wuichet K, Gödeke J, Starosta AL, Chen JM, Søgaard-Andersen L, Rohr J, Wilson DN, Häussler S, Mann M, Jung K. Corrigendum: Arginine-rhamnosylation as new strategy to activate translation elongation factor P. Nat Chem Biol. 2015 Apr;11(4):299. doi: 10.1038/nchembio0415-299d. PMID: 25785429.
Copy Download .nbib Format: NLM
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice.

Therapeutic advances in medical oncology

Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA.
PMID: 29449894
Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19.

BACKGROUND: Regorafenib (REG) has now been approved as the standard third-line therapy in metastatic gastrointestinal stromal tumour (GIST) patients at the recommended dose and schedule of 160 mg once daily for the first 3 weeks of each 4-week cycle....

Cite
Nannini M, Nigro MC, Vincenzi B, et al. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017;9(12):731-739doi: 10.1177/1758834017742627.
Nannini, M., Nigro, M. C., Vincenzi, B., Fumagalli, E., Grignani, G., D'Ambrosio, L., Badalamenti, G., Incorvaia, L., Bracci, R., Gasperoni, S., Saponara, M., Gatto, L., Indio, V., Astolfi, A., Di Scioscio, V., Casali, P. G., Tonini, G., Aglietta, M., Russo, A., Biasco, G., & Pantaleo, M. A. (2017). Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Therapeutic advances in medical oncology, 9(12), 731-739. https://doi.org/10.1177/1758834017742627
Nannini, Margherita, et al. "Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice." Therapeutic advances in medical oncology vol. 9,12 (2017): 731-739. doi: https://doi.org/10.1177/1758834017742627
Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19. PMID: 29449894; PMCID: PMC5808843.
Copy Download .nbib Format: NLM
[No title available]

Annals of gastroenterology

Zullo A, Hassan C, Francesco VD, Manta R, Romiti A, Gatta L.
PMID: 25331513
Ann Gastroenterol. 2014;27(4):291-293.

No abstract available.

Cite
Zullo A, Hassan C, Francesco VD, et al. . Ann Gastroenterol. 2014;27(4):291-293
Zullo, A., Hassan, C., Francesco, V. D., Manta, R., Romiti, A., & Gatta, L. (2014). . Annals of gastroenterology, 27(4), 291-293.
Zullo, Angelo, et al. "." Annals of gastroenterology vol. 27,4 (2014): 291-293.
Zullo A, Hassan C, Francesco VD, Manta R, Romiti A, Gatta L. . Ann Gastroenterol. 2014;27(4):291-293. PMID: 25331513; PMCID: PMC4188924.
Copy Download .nbib Format: NLM
Physician preferences for bone metastasis drug therapy in Canada.

Current oncology (Toronto, Ont.)

Arellano J, González JM, Qian Y, Habib M, Mohamed AF, Gatta F, Hauber AB, Posner J, Califaretti N, Chow E.
PMID: 26628874
Curr Oncol. 2015 Oct;22(5):e342-8. doi: 10.3747/co.22.2380.

BACKGROUND: Currently in Canada, several bone-targeted agents (btas) with varying characteristics are available for the prevention of skeletal-related events (sres) in patients with bone metastasis secondary to solid tumours. In the present study, we evaluated the preferences of physicians...

Cite
Arellano J, González JM, Qian Y, et al. Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol. 2015;22(5):e342-8doi: 10.3747/co.22.2380.
Arellano, J., González, J. M., Qian, Y., Habib, M., Mohamed, A. F., Gatta, F., Hauber, A. B., Posner, J., Califaretti, N., & Chow, E. (2015). Physician preferences for bone metastasis drug therapy in Canada. Current oncology (Toronto, Ont.), 22(5), e342-8. https://doi.org/10.3747/co.22.2380
Arellano, J, et al. "Physician preferences for bone metastasis drug therapy in Canada." Current oncology (Toronto, Ont.) vol. 22,5 (2015): e342-8. doi: https://doi.org/10.3747/co.22.2380
Arellano J, González JM, Qian Y, Habib M, Mohamed AF, Gatta F, Hauber AB, Posner J, Califaretti N, Chow E. Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol. 2015 Oct;22(5):e342-8. doi: 10.3747/co.22.2380. PMID: 26628874; PMCID: PMC4608407.
Copy Download .nbib Format: NLM
Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression.

European journal of internal medicine

Piga M, Passiu G, Carta P, Satta L, Cherchi V, Pala R, Sanna G, Cauli A, Tuveri MA, Aloe L, Mathieu A.
PMID: 10854822
Eur J Intern Med. 2000 Jun;11(3):156-160. doi: 10.1016/s0953-6205(00)00084-4.

Background: Nerve growth factor (NGF), a neurotrophic factor that indirectly induces fibroblast proliferation and collagen production, has been found to be increased in the affected dermis of patients with systemic sclerosis (SSc). To investigate the possibility of a relationship...

Cite
Piga M, Passiu G, Carta P, et al. Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression. Eur J Intern Med. 2000;11(3):156-160doi: 10.1016/s0953-6205(00)00084-4.
Piga, M., Passiu, G., Carta, P., Satta, L., Cherchi, V., Pala, R., Sanna, G., Cauli, A., Tuveri, M. A., Aloe, L., & Mathieu, A. (2000). Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression. European journal of internal medicine, 11(3), 156-160. https://doi.org/10.1016/s0953-6205(00)00084-4
Piga, et al. "Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression." European journal of internal medicine vol. 11,3 (2000): 156-160. doi: https://doi.org/10.1016/s0953-6205(00)00084-4
Piga M, Passiu G, Carta P, Satta L, Cherchi V, Pala R, Sanna G, Cauli A, Tuveri MA, Aloe L, Mathieu A. Increased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expression. Eur J Intern Med. 2000 Jun;11(3):156-160. doi: 10.1016/s0953-6205(00)00084-4. PMID: 10854822.
Copy Download .nbib Format: NLM
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature.

Journal of medical case reports

Grisanti S, Amoroso V, Buglione M, Rosati A, Gatta R, Pizzocaro C, Ferrari VD, Marini G.
PMID: 18826647
J Med Case Rep. 2008 Sep 30;2:320. doi: 10.1186/1752-1947-2-320.

INTRODUCTION: Patients with metastatic mucoepidermoid carcinoma of salivary glands have a poor outcome. The epidermal growth factor receptor protein is overexpressed in approximately 70% of mucoepidermoid carcinoma patients and may represent a therapeutic target. However, whether treatment with anti-epidermal...

Cite
Grisanti S, Amoroso V, Buglione M, et al. Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. J Med Case Rep. 2008;2:320doi: 10.1186/1752-1947-2-320.
Grisanti, S., Amoroso, V., Buglione, M., Rosati, A., Gatta, R., Pizzocaro, C., Ferrari, V. D., & Marini, G. (2008). Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. Journal of medical case reports, 2320. https://doi.org/10.1186/1752-1947-2-320
Grisanti, Salvatore, et al. "Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature." Journal of medical case reports vol. 2 (2008): 320. doi: https://doi.org/10.1186/1752-1947-2-320
Grisanti S, Amoroso V, Buglione M, Rosati A, Gatta R, Pizzocaro C, Ferrari VD, Marini G. Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. J Med Case Rep. 2008 Sep 30;2:320. doi: 10.1186/1752-1947-2-320. PMID: 18826647; PMCID: PMC2570365.
Copy Download .nbib Format: NLM
Psychological and behavioral disease during developmental age: the importance of the alliance with parents.

Neuropsychiatric disease and treatment

Gatta M, Ramaglioni E, Lai J, Svanellini L, Toldo I, Del Col L, Salviato C, Spoto A, Antonio BP.
PMID: 19898668
Neuropsychiatr Dis Treat. 2009;5:541-6. doi: 10.2147/ndt.s5880. Epub 2009 Nov 02.

The aim of the study is to analyze the clinician's alliance with parents during the diagnostic process in relation to therapeutic compliance and clinical evolution of individuals aged 0-11 years. The sample was formed by 84 individuals aged 0...

Cite
Gatta M, Ramaglioni E, Lai J, et al. Psychological and behavioral disease during developmental age: the importance of the alliance with parents. Neuropsychiatr Dis Treat. 2009;5:541-6doi: 10.2147/ndt.s5880.
Gatta, M., Ramaglioni, E., Lai, J., Svanellini, L., Toldo, I., Del Col, L., Salviato, C., Spoto, A., & Antonio, B. P. (2009). Psychological and behavioral disease during developmental age: the importance of the alliance with parents. Neuropsychiatric disease and treatment, 5541-6. https://doi.org/10.2147/ndt.s5880
Gatta, Michela, et al. "Psychological and behavioral disease during developmental age: the importance of the alliance with parents." Neuropsychiatric disease and treatment vol. 5 (2009): 541-6. doi: https://doi.org/10.2147/ndt.s5880
Gatta M, Ramaglioni E, Lai J, Svanellini L, Toldo I, Del Col L, Salviato C, Spoto A, Antonio BP. Psychological and behavioral disease during developmental age: the importance of the alliance with parents. Neuropsychiatr Dis Treat. 2009;5:541-6. doi: 10.2147/ndt.s5880. Epub 2009 Nov 02. PMID: 19898668; PMCID: PMC2773285.
Copy Download .nbib Format: NLM
Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life.

Hepatitis monthly

Mazzone L, Postorino V, De Peppo L, Della Corte C, Lofino G, Vassena L, Fatta L, Armando M, Bedogni G, Vicari S, Nobili V.
PMID: 23745129
Hepat Mon. 2013 Mar 12;13(3):e7871. doi: 10.5812/hepatmon.7871. Print 2013 Mar.

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the causes of fatty liver in adults and is currently the primary form of chronic liver disease in children and adolescents. However, the psychological outcome (i.e. the behavioural problems that...

Cite
Mazzone L, Postorino V, De Peppo L, et al. Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. Hepat Mon. 2013;13(3):e7871doi: 10.5812/hepatmon.7871.
Mazzone, L., Postorino, V., De Peppo, L., Della Corte, C., Lofino, G., Vassena, L., Fatta, L., Armando, M., Bedogni, G., Vicari, S., & Nobili, V. (2013). Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. Hepatitis monthly, 13(3), e7871. https://doi.org/10.5812/hepatmon.7871
Mazzone, Luigi, et al. "Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life." Hepatitis monthly vol. 13,3 (2013): e7871. doi: https://doi.org/10.5812/hepatmon.7871
Mazzone L, Postorino V, De Peppo L, Della Corte C, Lofino G, Vassena L, Fatta L, Armando M, Bedogni G, Vicari S, Nobili V. Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. Hepat Mon. 2013 Mar 12;13(3):e7871. doi: 10.5812/hepatmon.7871. Print 2013 Mar. PMID: 23745129; PMCID: PMC3669678.
Copy Download .nbib Format: NLM
Application of motor learning principles with stroke survivors.

Occupational therapy in health care

Schreiber J, Sober L, Banta L, Glassbrenner L, Haman J, Mistry N, Olesinski K.
PMID: 23941121
Occup Ther Health Care. 2001;13(1):23-44. doi: 10.1080/J003v13n01_03.

The purpose of this study was to determine the relationship between type of task and type of environment on retention and transfer of motor skills when applied to stroke survivors, as measured by time to complete the task and...

Cite
Schreiber J, Sober L, Banta L, et al. Application of motor learning principles with stroke survivors. Occup Ther Health Care. 2001;13(1):23-44doi: 10.1080/J003v13n01_03.
Schreiber, J., Sober, L., Banta, L., Glassbrenner, L., Haman, J., Mistry, N., & Olesinski, K. (2001). Application of motor learning principles with stroke survivors. Occupational therapy in health care, 13(1), 23-44. https://doi.org/10.1080/J003v13n01_03
Schreiber, J, et al. "Application of motor learning principles with stroke survivors." Occupational therapy in health care vol. 13,1 (2001): 23-44. doi: https://doi.org/10.1080/J003v13n01_03
Schreiber J, Sober L, Banta L, Glassbrenner L, Haman J, Mistry N, Olesinski K. Application of motor learning principles with stroke survivors. Occup Ther Health Care. 2001;13(1):23-44. doi: 10.1080/J003v13n01_03. PMID: 23941121.
Copy Download .nbib Format: NLM
Thrombosis of the portal venous system.

Journal of ultrasound

Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A.
PMID: 23396402
J Ultrasound. 2007 Mar;10(1):12-21. doi: 10.1016/j.jus.2007.02.007. Epub 2007 Apr 16.

Portal vein thrombosis (PVT) is a rare cause of portal hypertension. Its diagnosis has been facilitated by improvements in imaging techniques, in particular Doppler sonography. The prevalence is about 1% in the general population, but much higher rates are...

Cite
Sacerdoti D, Serianni G, Gaiani S, et al. Thrombosis of the portal venous system. J Ultrasound. 2007;10(1):12-21doi: 10.1016/j.jus.2007.02.007.
Sacerdoti, D., Serianni, G., Gaiani, S., Bolognesi, M., Bombonato, G., & Gatta, A. (2007). Thrombosis of the portal venous system. Journal of ultrasound, 10(1), 12-21. https://doi.org/10.1016/j.jus.2007.02.007
Sacerdoti, D, et al. "Thrombosis of the portal venous system." Journal of ultrasound vol. 10,1 (2007): 12-21. doi: https://doi.org/10.1016/j.jus.2007.02.007
Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A. Thrombosis of the portal venous system. J Ultrasound. 2007 Mar;10(1):12-21. doi: 10.1016/j.jus.2007.02.007. Epub 2007 Apr 16. PMID: 23396402; PMCID: PMC3478708.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 393 entries